AI MARKET SCANNING

Cocrystal Pharma, Inc.

📅 Next Catalyst: Nov 12, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP +0.03%
MAX GAP RECORD +5.48%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $COCP
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 12, 2026 Earnings Release 2026-11-12 (UNDETERMINED) 🔮 UPCOMING 🔒
Aug 17, 2026 Earnings Release 2026-08-17 (BEFORE OPEN)
+1.79%
Mar 31, 2026 Earnings Release 2026-03-31 (BEFORE OPEN)
+0.00%
Nov 14, 2025 Earnings Release 2025-11-14 (BEFORE OPEN)
+1.94%
Aug 14, 2025 Earnings Release 2025-08-14 (BEFORE OPEN)
-0.60%
May 15, 2025 Earnings Release 2025-05-15 (BEFORE OPEN)
+5.48%
Nov 13, 2024 Earnings Release 2024-11-13 (BEFORE OPEN)
-3.41%
Aug 14, 2024 Earnings Release 2024-08-14 (BEFORE OPEN)
-3.16%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.0%
Bullish Gaps (6)
Bearish Gaps (5)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $COCP

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. The company employs structure-based technologies to create antiviral drugs including influenza virus, norovirus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as respiratory virus…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗